Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) is now available.
WuXi AppTec Co., Ltd., a China-based pharmaceutical and life-sciences services provider listed in Hong Kong, serves global healthcare and biopharma clients with a broad range of R&D and related services. Its H shares are traded on the Hong Kong Stock Exchange under stock code 2359, giving international investors exposure to China’s contract research and development sector.
The company has updated the timetable for payment of its 2025 Profit Distribution and related final dividend for H shareholders, extending key dates so investors have more time to review dividend information and participate. The revised schedule shifts the cum- and ex-entitlement trading days, the record date, the book closure period and the expected dividend payment date, providing clearer visibility on when shareholders must be on the register to receive the distribution and when cash is expected to be paid.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$150.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a China-incorporated company listed in Hong Kong as an H-share issuer. It operates in the pharmaceutical and life-sciences services industry, providing research, development and related services that enable global healthcare and biopharma companies to advance drug discovery and development. The company’s H shares trade under stock code 2359 on the Hong Kong Stock Exchange.
Average Trading Volume: 4,684,003
Technical Sentiment Signal: Buy
Current Market Cap: HK$339.2B
See more data about 2359 stock on TipRanks’ Stock Analysis page.